IMP
Process View
regulation of metanephros development
Any process that modulates the rate, frequency or extent of metanephros development. Metanephros development is the process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of metanephros development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.903 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.882 | ||
| VEGFA | vascular endothelial growth factor A | 0.355 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.160 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.112 | ||
| NRP1 | neuropilin 1 | 0.101 | ||
| NKX2-1 | NK2 homeobox 1 | 0.091 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.067 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.062 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.056 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.055 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.051 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.050 | ||
| IER2 | immediate early response 2 | 0.040 | ||
| EGR3 | early growth response 3 | 0.036 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.034 | Mouse | |
| TJP2 | tight junction protein 2 (zona occludens 2) | 0.033 | ||
| AMOTL1 | angiomotin like 1 | 0.030 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.029 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.026 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.026 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.024 | ||
| EGFR | epidermal growth factor receptor | 0.024 | ||
| EGR2 | early growth response 2 | 0.023 | ||
| JUNB | jun B proto-oncogene | 0.021 | ||
| AMOTL2 | angiomotin like 2 | 0.020 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.020 | ||
| STC1 | stanniocalcin 1 | 0.017 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.017 | ||
| PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.017 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.016 | ||
| TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | 0.016 | ||
| MPDZ | multiple PDZ domain protein | 0.016 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.016 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.015 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.015 | ||
| FOSL1 | FOS-like antigen 1 | 0.014 | ||
| RUNX1 | runt-related transcription factor 1 | 0.014 | ||
| HNF1A | HNF1 homeobox A | 0.014 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.014 | ||
| TEAD4 | TEA domain family member 4 | 0.014 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.014 | ||
| AES | amino-terminal enhancer of split | 0.014 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.013 | ||
| NOG | noggin | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.012 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.011 | ||
| AMOT | angiomotin | 0.011 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.011 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.011 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.011 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.011 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.011 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.011 | ||
| JUN | jun proto-oncogene | 0.011 | ||
| OSMR | oncostatin M receptor | 0.011 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.011 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.010 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.010 | ||
| SIM2 | single-minded homolog 2 (Drosophila) | 0.010 | ||
| TAOK1 | TAO kinase 1 | 0.010 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.010 |